SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950123-05-010360
Filing Date
2005-08-25
Accepted
2005-08-25 16:55:36
Documents
2
Group Members
BIOMEDICAL OFFSHORE VALUE FUND LTD.BIOMEDICAL VALUE FUND LPDR. JEFFREY R. JAY MD

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 TO SC 13D y12294sc13dza.txt SC 13D/A 49421
2 EX-99.G: JOINT FILING AGREEMENT y12294exv99wg.txt EX-99.G 2645
  Complete submission text file 0000950123-05-010360.txt   54148
Mailing Address 134 COOLIDGE AVE WATERTOWN MA 02472
Business Address 134 COOLIDGE AVE WATERTOWN MA 02472 617-926-1551
PANACOS PHARMACEUTICALS, INC. (Subject) CIK: 0001040017 (see all company filings)

IRS No.: 113238476 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-55237 | Film No.: 051049427
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 2 PICKWICK PLAZA STE 450 GREENWICH CT 06830
Business Address
GREAT POINT PARTNERS LLC (Filed by) CIK: 0001281446 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A